Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours (Q41703426)

7 October 2017

title

Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours (English)

1 reference

7 October 2017

Qiu Rao

1

1 reference

7 October 2017

Qiu-yuan Xia

2

1 reference

7 October 2017

Zi-yu Wang

3

1 reference

7 October 2017

Li Li

4

1 reference

7 October 2017

Qin Shen

5

1 reference

7 October 2017

Shan-shan Shi

6

1 reference

7 October 2017

Xuan Wang

7

1 reference

7 October 2017

Biao Liu

8

1 reference

7 October 2017

Yan-fen Wang

9

1 reference

7 October 2017

Qun-li Shi

10

1 reference

7 October 2017

Heng-hui Ma

11

1 reference

7 October 2017

Zhen-feng Lu

12

1 reference

7 October 2017

Yan He

13

1 reference

7 October 2017

Ru-song Zhang

14

1 reference

7 October 2017

Bo Yu

15

1 reference

7 October 2017

Xiao-jun Zhou

16

1 reference

7 October 2017

publication date

13 December 2014

1 reference

7 October 2017

1 reference

7 October 2017

volume

67

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

121-129

1 reference

INI1-deficient tumors: diagnostic features and molecular genetics

7 October 2017

cites work

1 reference

Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype

21 January 2018

1 reference

Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity

21 January 2018

1 reference

The SWI/SNF complex and cancer

21 January 2018

1 reference

SWI/SNF nucleosome remodellers and cancer.

21 January 2018

1 reference

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

21 January 2018

1 reference

SMARCB1/INI1 inactivation in renal medullary carcinoma.

21 January 2018

1 reference

Loss of PBRM1 expression is associated with renal cell carcinoma progression

21 January 2018

1 reference

SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma

21 January 2018

1 reference

Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions

21 January 2018

1 reference

Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.

21 January 2018

1 reference

Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits

21 January 2018

1 reference

Identifying targets for the restoration and reactivation of BRM.

21 January 2018

1 reference

Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome

21 January 2018

1 reference

The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential

21 January 2018

1 reference

Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology

21 January 2018

1 reference

Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas

21 January 2018

1 reference

Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors

21 January 2018

1 reference

Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas

21 January 2018

1 reference

The spectrum of SWI/SNF mutations, ubiquitous in human cancers

21 January 2018

1 reference

The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.

21 January 2018

1 reference

When the SWI/SNF complex remodels...the cell cycle

21 January 2018

1 reference

Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.

21 January 2018

1 reference

BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer

21 January 2018

1 reference

Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence

21 January 2018

1 reference

Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy

21 January 2018

1 reference

Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12632

1 reference

7 October 2017

1 reference